175 related articles for article (PubMed ID: 9508188)
21. [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
Nakabayashi T; Yasuda S; Miyamoto H; Abe S; Ohosaki Y
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2998-3004. PubMed ID: 2429619
[TBL] [Abstract][Full Text] [Related]
22. A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.
Kurihara M; Izumi T; Yoshida S; Ohkubo T; Suga S; Kiyohashi A; Yaosaka T; Takahashi H; Ito T; Sasai T
Jpn J Cancer Res; 1991 May; 82(5):613-20. PubMed ID: 1905707
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer].
Mitomi T; Kyoji-Ogoshi
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2532-7. PubMed ID: 3090939
[TBL] [Abstract][Full Text] [Related]
24. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
25. [Postoperative adjuvant immunochemotherapy with bestatin for stomach cancer. Randomized controlled trial: first report].
Yoshinaka K; Nakano A; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1458-64. PubMed ID: 3925887
[TBL] [Abstract][Full Text] [Related]
26. [Effect of adjuvant chemotherapy for patients with early gastric cancer].
Sasaki A; Furusawa M; Tomoda H; Seo Y; Ohno S; Matsukuma A; Morita M; Kakeji Y
Gan To Kagaku Ryoho; 1994 Jan; 21(1):37-45. PubMed ID: 8291914
[TBL] [Abstract][Full Text] [Related]
27. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
28. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
[TBL] [Abstract][Full Text] [Related]
29. Postoperative adjuvant chemotherapy for gastric carcinoma. Analysis of data on 1805 patients followed for 5 years.
Inokuchi K; Hattori T; Taguchi T; Abe O; Ogawa N
Cancer; 1984 Jun; 53(11):2393-7. PubMed ID: 6424926
[TBL] [Abstract][Full Text] [Related]
30. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
[TBL] [Abstract][Full Text] [Related]
31. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
32. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
[TBL] [Abstract][Full Text] [Related]
33. Prospective randomized controlled study on bestatin in resectable gastric cancer--third report.
Niimoto M; Saeki T; Toi M; Nishiyama M; Hirai T; Yanagawa E; Hattori T
Jpn J Surg; 1990 Mar; 20(2):186-91. PubMed ID: 2111415
[TBL] [Abstract][Full Text] [Related]
34. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
[TBL] [Abstract][Full Text] [Related]
35. [Combined UFTM for 140 patients with advanced gastric cancer].
Jin ML
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):130-2. PubMed ID: 2553364
[TBL] [Abstract][Full Text] [Related]
36. 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
Ahn MS; Kang SY; Lee HW; Jeong SH; Park JS; Lee KJ; Cho YK; Han SU; Lee SY; Lim HY; Choi JH
Onkologie; 2013; 36(7-8):421-6. PubMed ID: 23921761
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer.
Nakajima T; Kinoshita T; Nashimoto A; Sairenji M; Yamaguchi T; Sakamoto J; Fujiya T; Inada T; Sasako M; Ohashi Y;
Br J Surg; 2007 Dec; 94(12):1468-76. PubMed ID: 17948223
[TBL] [Abstract][Full Text] [Related]
38. Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan.
Morimoto T; Ogawa M; Orita K; Sugimachi K; Toge T; Dohi K; Nomura Y; Monden Y; Ogawa N
Eur J Cancer; 1996 Feb; 32A(2):235-42. PubMed ID: 8664034
[TBL] [Abstract][Full Text] [Related]
39. [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy].
Sano T; Nomura K; Adachi M; Kobori O
Gan No Rinsho; 1990 Jan; 36(1):97-100. PubMed ID: 2105405
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.
Tsavaris N; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekas D; Tsetis A; Klonaris C
Chemotherapy; 1996; 42(3):220-6. PubMed ID: 8983891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
